Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

limma powers differential expression analyses for RNA-sequencing and microarray studies

Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458

voom: precision weights unlock linear model analysis tools for RNA-seq read counts

Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155

Comprehensive molecular characterization of clear cell renal cell carcinoma

The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485

MethPrimer: designing primers for methylation PCRs

Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,741

Regulatory networks defining EMT during cancer initiation and progression

Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635

The impact of O2 availability on human cancer

Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365

Direct regulation of TWIST by HIF-1α promotes metastasis

Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336

Exploiting the metabolic vulnerability of circulating tumour cells

Merteroglu, M., & Santoro, M. M. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.03.004 · Cited by 22

Fumarate hydratase as a therapeutic target in renal cancer

Kancherla, P., Daneshvar, M., Sager, R., Mollapour, M., & Bratslavsky, G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1804862 · Cited by 20

Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma

Wang, Q., Tan, Y., Jiang, T., Wang, X., Li, Q., Li, Y., Dong, L., Liu, X., & Xu, G. (2022) · Cells · doi:10.3390/cells11071066 · Cited by 20

Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1

Han, L., Zhang, C., Wang, D., Zhang, J., Tang, Q., Li, M. J., Sack, M. N., Wang, L., & Zhu, L. (2023) · Oncogene · doi:10.1038/s41388-023-02621-w · Cited by 20

Mitochondrial Alterations in Prostate Cancer: Roles in Pathobiology and Racial Disparities

Vikramdeo, K. S., Sharma, A., Anand, S., Sudan, S. K., Singh, S., Singh, A. P., & Dasgupta, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054482 · Cited by 20

Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma

Ramesh, V., Gollavilli, P. N., Pinna, L., Siddiqui, A., Martinez-Turtos, A., Napoli, F., Antonelli, Y., Leal‐Egaña, A., Havelund, J. F., Jakobsen, S. T., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317836 · Cited by 21

A new holistic 3D non-invasive analysis of cellular distribution and motility on fibroin-alginate microcarriers using light sheet fluorescent microscopy

Duchi, S., Piccinini, F., Pierini, M., Bevilacqua, A., Torre, M. L., Lucarelli, E., & Santi, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183336 · Cited by 20

Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinoma

DiNatale, R. G., Sánchez, A., Hakimi, A. A., & Reznik, E. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2019.04.028 · Cited by 20

The role of TET-mediated DNA hydroxymethylation in prostate cancer

Smeets, E., Lynch, A. G., Preković, S., den Broeck, T. V., Moris, L., Helsen, C., Joniau, S., Claessens, F., & Massie, C. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.021 · Cited by 20

Beyond energy: how TCA cycle-derived metabolites regulate gene expression and inflammation in the nucleus

Randhawa, J., & Pålsson‐McDermott, E. M. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00461-x · Cited by 21

Tolerance to NADH/NAD+ imbalance anticipates aging and anti-aging interventions

Alonso-Lavin, A. J., Bajić, D., & Poyatos, J. F. (2021) · iScience · doi:10.1016/j.isci.2021.102697 · Cited by 17

SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism

Wang, Y., Gao, J.-W., Hu, S., Zeng, W., Yang, H., Chen, H., & Wang, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682710 · Cited by 19

Restraint of Fumarate Accrual by HIF-1α Preserves miR-27a-Mediated Limitation of Interleukin 10 during Infection of Macrophages by Histoplasma capsulatum

Evans, H. M., Schultz, D. F., Boiman, A. J., McKell, M. C., Qualls, J. E., & Deepe, G. S. (2021) · mBio · doi:10.1128/mbio.02710-21 · Cited by 19

Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness

Chen, S., Wu, Y., Gao, Y., Wu, C., Wang, Y., Hou, C., Ren, M., Zhang, S., Zhu, Q., Zhang, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113246 · Cited by 20

A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation

Liu, R., Zhao, D., Zhang, X., Han, S., Yang, Y.-Y., Ma, J., & Meng, D. (2017) · Oncotarget · doi:10.18632/oncotarget.21860 · Cited by 19

Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery

Gambichler, T., Rüddel, I., Hessam, S., Bechara, F. G., Stockfleth, E., & Schmitz, L. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14887 · Cited by 19

Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition

Cevatemre, B., Ulukaya, E., Dere, E., Dilege, Ş., & Açılan, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.738916 · Cited by 19

Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets

Zhang, X., Zhao, J., Yin, X., Liang, J., Wang, Y., Zheng, L., Tan, P., Lin, Y., Xu, N., Zhu, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59513-8 · Cited by 18

TET Enzymes as Oxygen-Dependent Tumor Suppressors: Exciting New Avenues for Cancer Management

Thienpont, B., Galle, E., & Lambrechts, D. (2016) · Epigenomics · doi:10.2217/epi-2016-0126 · Cited by 19

Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)

Ricketts, C. J., Killian, J. K., Vocke, C. D., Wang, Y., Merino, M. J., Meltzer, P. S., & Linehan, W. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278108 · Cited by 18

Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma

Fitzsimmons, C. M., Mandler, M. D., Lunger, J. C., Chan, D., Maligireddy, S. S., Schmiechen, A. C., Gamage, S. T., Link, C. N., Jenkins, L. M. M., Chan, K. C., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcae004 · Cited by 18

Oncometabolite Accumulation and Epithelial-to-Mesenchymal Transition: The Turn of Fumarate

Janin, M., & Esteller, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.020 · Cited by 18

Metabolic Alterations at the Crossroad of Aging and Oncogenesis

Raffaghello, L., & Longo, V. D. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.003 · Cited by 19

A metabolomic explanation on beneficial effects of dietary Goji on intestine inflammation

Wang, H., Zhang, S., Shen, Q. W., & Zhu, M. J. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.12.014 · Cited by 18

Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAM e‐Dnmts axis

Strmiska, V., Michálek, P., Lacková, Z., Guráň, R., Křížková, S., Vaníčková, L., Zítka, O., Stiborová, M., Eckschlager, T., Klejdus, B., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12439 · Cited by 18

Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights

Chen, Y., Hu, H.-H., Wang, Y., Liu, J., Liu, H., Liu, J., & Zhao, Y. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108623 · Cited by 18

The role of glycometabolic plasticity in cancer

Peng, Y., Yang, H., & Li, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153595 · Cited by 17

Hypoxia signaling and oxygen metabolism in cardio-oncology

Baik, A. H. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.12.013 · Cited by 20

A Short Isoform of Spermatogenic Enzyme GAPDHS Functions as a Metabolic Switch and Limits Metastasis in Melanoma

Gill, J. G., Leef, S. N., Ramesh, V., Martin-Sandoval, M. S., Rao, A. D., West, L., Muh, S., Gu, W., Zhao, Z., Hosler, G. A., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2062 · Cited by 18

Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment

Adhikari, S., Guha, D., Mohan, C., Mukherjee, S., Tyler, J. K., & Das, C. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_1 · Cited by 19

Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis

Williams, D., & Fingleton, B. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09967-0 · Cited by 16

Mitochondria-driven elimination of cancer and senescent cells

Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 19

Correction: Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., et al. (2016) · Nature · doi:10.1038/nature20144 · Cited by 17

Metabolism-epigenetic interactions on in vitro produced embryos

Milazzotto, M. P., Ispada, J., & de Lima, C. B. (2022) · Reproduction Fertility and Development · doi:10.1071/rd22203 · Cited by 16

Metabolic dialogs between B cells and the tumor microenvironment: Implications for anticancer immunity

Jiang, S., Feng, R., Tian, Z., Zhou, J., & Zhang, W. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216076 · Cited by 16

Vitamin B2 enables regulation of fasting glucose availability

Masschelin, P. M., Saha, P., Ochsner, S. A., Cox, A. R., Kim, K. H., Felix, J. B., Sharp, R., Li, X., Tan, L., Park, J. H., et al. (2023) · eLife · doi:10.7554/elife.84077 · Cited by 14

The de novo synthesis of GABA and its gene regulatory function control hepatocellular carcinoma metastasis

Li, L., Kang, Y., Cheng, R., Liu, F., Wu, F., Liu, Z., Kou, J., Zhang, Z., Li, J., Zhao, H., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.12.007 · Cited by 21

Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers

Rogers, L. C., & Tine, B. A. V. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.49 · Cited by 17

Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes

Podkalicka, P., Mucha, O., Kruczek, S., Biela, A., Andrysiak, K., Stępniewski, J., Mikulski, M., Gałȩzowski, M., Sitarz, K. S., Brzózka, K. D., et al. (2020) · Biomolecules · doi:10.3390/biom10010143 · Cited by 17

Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial Dysfunction

Madala, H. R., Helenius, I. T., Zhou, W., Mills, E. L., Zhang, Y., Liu, Y., Metelo, A. M., Kelley, M. L., Punganuru, S. R., Kim, K. B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0246 · Cited by 19

Exploiting tumour addiction with a serine and glycine-free diet

Amelio, I., Melino, G., & Frezza, C. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.83 · Cited by 15

Using chemical biology to assess and modulate mitochondria: progress and challenges

Logan, A., & Murphy, M. P. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0151 · Cited by 15

Metabolic enzymes function as epigenetic modulators: A Trojan Horse for chromatin regulation and gene expression

Liao, X., Guo, Y., He, Y., Xiao, Y., Li, J., & Liu, R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105834 · Cited by 14

HIF-1α mediates renal fibrosis by regulating metabolic remodeling of renal tubule epithelial cells

Liu, D., Sun, H., Li, K., Zhao, Z., Liu, Z., Zhang, G., Ge, Y., Zhang, J., Wang, D., & Leng, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.008 · Cited by 16

Non-Coding RNAs Derived from Extracellular Vesicles Promote Pre-Metastatic Niche Formation and Tumor Distant Metastasis

Cheng, J., Zhang, K., Qu, C., Peng, J., & Yang, L. (2023) · Cancers · doi:10.3390/cancers15072158 · Cited by 15

Review of pre-metastatic niches induced by osteosarcoma-derived extracellular vesicles in lung metastasis: A potential opportunity for diagnosis and intervention

Zhongyu, X., Xu, W., Hongmei, Z., Xiaodong, G., Xiaojing, Y., Yuanpei, L., Zhu, L., Zhenmin, F., & Xu, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117203 · Cited by 16

Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma

Yang, C., Cui, X., Ding, Z., Jiang, T., Feng, X., Pan, Y., Lin, Y., Shang, T., Wang, Q., Pan, J., et al. (2022) · Cancer Science · doi:10.1111/cas.15593 · Cited by 14

DDR2 Coordinates EMT and Metabolic Reprogramming as a Shared Effector of FOXQ1 and SNAI1

Mitchell, A. V., Wu, J., Meng, F., Dong, L., Block, C. J., Song, W., Zhang, B., Li, J., & Wu, G. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0013 · Cited by 14

Mitonuclear Communication in Stem Cell Function

Peng, B., Wang, Y., & Zhang, H. (2024) · Cell Proliferation · doi:10.1111/cpr.13796 · Cited by 14

Analysis of Epithelial-Mesenchymal Transition Metabolism Identifies Possible Cancer Biomarkers Useful in Diverse Genetic Backgrounds

Matadamas-Guzman, M. L., Zazueta, C., Rojas, E., & Reséndis-Antonio, O. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01309 · Cited by 14

An update on adult forms of hereditary pheochromocytomas and paragangliomas

Dariane, C., Goncalves, J., Timsit, M., & Favier, J. (2020) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000694 · Cited by 14

HIRA loss transforms FH -deficient cells

Valcárcel-Jiménez, L., Rogerson, C., Yong, C., Schmidt, C., Yang, M. H., Cremades-Rodelgo, M., Harle, V. J., Offord, V., Wong, K., Mora, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq8297 · Cited by 14

Metabolic Reprogramming of Castration-Resistant Prostate Cancer Cells as a Response to Chemotherapy

Petrella, G., Corsi, F., Ciufolini, G., Germini, S., Capradossi, F., Pelliccia, A., Torino, F., Ghibelli, L., & Cicero, D. O. (2022) · Metabolites · doi:10.3390/metabo13010065 · Cited by 14

Nichtkanonische Basen im Genom: die regulative Informationsebene in der DNA

Carell, T., Kurz, M. Q., Müller, M., Rossa, M., & Spada, F. (2017) · Angewandte Chemie · doi:10.1002/ange.201708228 · Cited by 14

The cytochrome P450 CYP77A4 is involved in auxin-mediated patterning of the Arabidopsis thaliana embryo

Kawade, K., Li, Y., Koga, H., Sawada, Y., Okamoto, M., Kuwahara, A., Tsukaya, H., & Hirai, M. Y. (2018) · Development · doi:10.1242/dev.168369 · Cited by 15

Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications

Yang, J., Miao, D., Li, X., Zhao, C., Tan, D., Wu, S., Lu, F., Shi, J., Lv, Q., Ruan, H., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1664292 · Cited by 15

RNA-Sequencing Analysis of Paternal Low-Protein Diet-Induced Gene Expression Change in Mouse Offspring Adipocytes

Ly, N. H., Maekawa, T., Yoshida, K., Liu, Y., Muratani, M., & Ishii, S. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400181 · Cited by 15

Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women

Balasubramanian, R., Demler, O., Guasch‐Ferré, M., Paynter, N. P., Sheehan, R. M., Liu, S., Manson, J. E., Salas‐Salvadó, J., Martínez‐González, M. Á., Hu, F. B., et al. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002977 · Cited by 13

The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects

Singh, R., & Mills, I. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704353 · Cited by 13

Role of mitochondria in regulating immune response during bacterial infection

Khan, S., Basu, S., Raj, D., & Lahiri, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.10.004 · Cited by 13

CD8+ T cell stressors converge on shared metabolic–epigenetic networks

Shangguan, Y., Wang, J., Ho, P., & Xu, Y. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.08.009 · Cited by 14

Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications

Psvv, C., Sunil, S., Thuyyath, N., Kokkanti, R. R., & Lavudi, K. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1741800 · Cited by 13

Multi-omics reveal disturbance of glucose homeostasis in pregnant rats exposed to short-chain perfluorobutanesulfonic acid

Yu, G., Luo, T., Liu, Y., Huo, X., Mo, C., Huang, B., Li, Y., Feng, L., Sun, Y., Zhang, J., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116402 · Cited by 12

Photoinducible Oncometabolite Detection

Kulkarni, R. A., Briney, C. A., Crooks, D. R., Bergholtz, S. E., Mushti, C., Lockett, S., Lane, A. N., Fan, T. W. ‐., Swenson, R. E., Linehan, W. M., et al. (2018) · ChemBioChem · doi:10.1002/cbic.201800651 · Cited by 12

Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer

Wu, Z., Lee, Y. F., Yeo, X. H., Loo, S. Y., & Tam, W. L. (2021) · Cancers · doi:10.3390/cancers13061316 · Cited by 14

Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression

Jakoubě, P., Cutano, V., González-Morena, J. M., & Keckesova, Z. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0518 · Cited by 13

TCA cycle off, ATF4 on for metabolic homeostasis

Mahor, D., Pandey, R., & Bulusu, V. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.03.006 · Cited by 13

Fumarate hydratase inhibits non‑small cell lung cancer metastasis via inactivation of AMPK and upregulation of DAB2

Vadhan, A., Yang, Y., Wang, Y., Chen, P., Tzou, S.-C., Cheng, K., Hu, S. C., Cheng, T., Wang, Y., & Yuan, S. F. (2022) · Oncology Letters · doi:10.3892/ol.2022.13627 · Cited by 12

FOXA2 controls the anti-oxidant response in FH-deficient cells

Rogerson, C., Sciacovelli, M., Maddalena, L. A., Pouikli, A., Segarra‐Mondejar, M., Valcárcel-Jiménez, L., Schmidt, C., Yang, M. H., Ivanova, E., Kent, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112751 · Cited by 13

Combined effects of FH (E404D) and ACOX2 (R409H) cause metabolic defects in primary cardiac malignant tumor

Zhou, X., Xu, M., Zeng, W., Chen, Z., Lu, G., Gong, Y., Finnell, R. H., Xiao, H., Qiao, B., & Wang, H. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0072-3 · Cited by 12

Current opportunities to catalyze research in nutrition and cancer prevention – an interdisciplinary perspective

The Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group (2019) · BMC Medicine · doi:10.1186/s12916-019-1383-9 · Cited by 13

Urine Tricarboxylic Acid Cycle Metabolites and Risk of End-stage Kidney Disease in Patients With Type 2 Diabetes

Liu, J., Liu, S., Zheng, H., Lee, J., Gurung, R. L., Chan, C., Lee, L. S., Ang, K., Ching, J., Kovalik, J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae199 · Cited by 11

Horizon Scanning in Cancer Genomics: How Advances in Genomic Medicine Will Change Cancer Care Over the Next Decade

Seed, L. M. (2021) · Current Genetic Medicine Reports · doi:10.1007/s40142-021-00200-7 · Cited by 11

REGLIV: Molecular regulation data of diverse living systems facilitating current multiomics research

Zhang, S., Sun, X., Mou, M., Amahong, K., Sun, H., Zhang, W., Shi, S., Li, Z., Gao, J., & Zhu, F. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105825 · Cited by 11

An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration

Cao, Z., Lin, J., Fu, G., Niu, L., Yang, Z., & Cai, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959967 · Cited by 11

Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects

Zhong, H., Pan, R., Ouyang, Y., Xiao, T., Gu, W., Yang, H., Wang, H., Li, H., Peng, T., & Chen, P. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02571-3 · Cited by 13

Fumarate induces LncRNA-MIR4435-2HG to regulate glutamine metabolism remodeling and promote the development of FH-deficient renal cell carcinoma

Zhu, L., Hong, Y., Zhu, Z.-R., Huang, J., Wang, J., Li, G., Wu, X., Chen, Y., Xu, Y., Zheng, L., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06510-2 · Cited by 11

Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression

Matsui, S., Ri, C., Bolanos, L. C., Choi, K., Shibamiya, A., Ishii, A., Takaishi, K., Oshima‐Hasegawa, N., Tsukamoto, S., Takeda, Y., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02245-3 · Cited by 10

F-ATP synthase inhibitory factor 1 and mitochondria-organelle interactions: New insight and implications

Guo, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107393 · Cited by 13

An Oncometabolite Isomer Rapidly Induces a Pathophysiological Protein Modification

Bergholtz, S. E., Briney, C. A., Najera, S. S., Perez, M., Linehan, W. M., & Meier, J. L. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00044 · Cited by 10

The epigenetic–metabolic interplay in gliomagenesis

Phasaludeen, B., Emerald, B. S., & Ansari, S. A. (2022) · Open Biology · doi:10.1098/rsob.210350 · Cited by 10

On mitochondrial metabolism in tumor biology

Shoshan, M. C. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000336 · Cited by 10

More than a powerplant: the influence of mitochondrial transfer on the epigenome

Patananan, A. N., Sercel, A. J., & Teitell, M. A. (2017) · Current Opinion in Physiology · doi:10.1016/j.cophys.2017.11.006 · Cited by 11

Cell death in cancer in the era of precision medicine

Raschellà, G., Melino, G., & Gambacurta, A. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0048-6 · Cited by 10

Low-Grade Fumarate Hydratase-Deficient Renal Cell Carcinoma in a 30-Year-Old Female

Wyvekens, N., Anderson, W. J., Kim, Y. X., Carter, M., & Hirsch, M. S. (2021) · International Journal of Surgical Pathology · doi:10.1177/10668969211026241 · Cited by 10

Krebs Cycle Rewired: Driver of Atherosclerosis Progression?

Liang, Y., Chen, Y., Lü, L., Zhang, S., Xiao, J., & Wei, D. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210806105246 · Cited by 11

Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencingPreprint

Huang, Y., Wu, G., Bi, G., Cheng, L., Liang, J., Li, M., Zhang, H., Shan, G., Hu, Z., Chen, Z., et al. (2024) · eLife · doi:10.7554/elife.95988 · Cited by 10

Mitochondria dysfunction in circulating tumor cells

Agnoletto, C., & Volinia, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947479 · Cited by 9

Mitochondrial fumarate promotes ischemia/reperfusion‐induced tubular injury

Li, Z., Huang, M., Yu, M., Nie, D., Fu, S., Di, J., Lan, T., Liu, B., & Wu, Q. (2024) · Acta Physiologica · doi:10.1111/apha.14121 · Cited by 9

NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion

Noronha, K. J., Lucas, K. N., Paradkar, S., Edmonds, J., Friedman, S., Murray, M. A., Liu, S., Sajed, D. P., Sachs, C. R., Spurrier, J. M., et al. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-1003 · Cited by 9

Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance

Álvarez-González, E., & Sierra, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169054 · Cited by 10

Diazo-carboxyl Click Derivatization Enables Sensitive Analysis of Carboxylic Acid Metabolites in Biosamples

Li, C., Cheng, K., Zhao, Q., Li, J., Wang, X., Liufu, T., Zhao, X., Li, X., Wang, X. D., Lyu, J., et al. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c03277 · Cited by 9

Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms

Nemours, S., Armesto, M., Arestin, M., Manini, C., Giustetto, D., Sperga, M., Pivovarčíková, K., Pérez‐Montiel, D., Hes, O., Michal, M., et al. (2024) · Pathology · doi:10.1016/j.pathol.2023.11.013 · Cited by 9

Identification of Two Novel CIL-102 Upregulations of ERP29 and FUMH to Inhibit the Migration and Invasiveness of Colorectal Cancer Cells by Using the Proteomic Approach

Cheng, K., Kuo, H., Hsieh, M., Huang, C.-Y., Teng, C., Tung, S., Shen, C., Lee, K.-F., Yang, Y.-L., & Lee, K. (2021) · Biomolecules · doi:10.3390/biom11091280 · Cited by 9

Genetics and epigenetics in conventional chondrosarcoma with focus on non-coding RNAs

Roessner, A., Franke, S., Schreier, J., Ullmann, S. R., Karras, F., & Jechorek, D. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154172 · Cited by 9

Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites

Bezwada, D., & Brugarolas, J. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170195 · Cited by 9

Iron, Copper, and Selenium: Cancer's Thing for Redox BlingPreprint

Terzi, E. M., & Possemato, R. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041545 · Cited by 9

The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation

Turano, M., Vicidomini, R., Cammarota, F., D’Agostino, V., Duraturo, F., Izzo, P., & Rosa, M. D. (2023) · Biomedicines · doi:10.3390/biomedicines11051428 · Cited by 9

Molecular Biomarkers of Glioma

Rajakaruna, P., Rios, S., Elnahas, H., Villanueva, A., Uribe, D., Leslie, S., Abbas, W. A., Barroso, L., Oyervides, S., Persans, M. W., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13061298 · Cited by 8

Fumarates and Cancer

Fuhler, G. M., Eppinga, H., & Peppelenbosch, M. P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.12.001 · Cited by 27

Oncometabolite Accumulation and Epithelial-to-Mesenchymal Transition: The Turn of Fumarate

Janin, M., & Esteller, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.020 · Cited by 18

Fumarate drives EMT in renal cancer

Sciacovelli, M., & Frezza, C. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.137 · Cited by 30

One way fumarate can promote metastasis

VanHook, A. M. (2016) · Science Signaling · doi:10.1126/scisignal.aak9768

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition (vol 537, pg 544, 2016)

Sciacovelli, M., Gonçalves, E., Johnson, T. E., Zecchini, V. R., da Costa, A., Gaude, E., Drubbel, A., Theobald, S., Abbo, Sr., Maxine, G., et al. (2016) · UCL Discovery (University College London)